Bid outcomes
How their decided bids ended, by number and by valueWhere they win
8 authorities · 5 statesTop buyer organisations
Operating states
1 award on central/PSU portals carry no state
Top competitors
In tenders they both bid · bar shows how the awards splitRecent tenders awarded to HINDUSTAN LABORATORIES
- Sch 2 - Supply of Tablets and CapsulesMunicipal Corporation of Greater Mumbai · Maharashtra · 30 Jul 2026₹53.5 Cr
- E-215/MMGPA/ Essential Medicines (2025-26)Maharashtra Medical Goods Procurement Authority Mumbai · Maharashtra · 25 Jul 2026₹178.8 Cr
- E-206/MMGPA/ Tablet Capsule Phase III (DHS)Maharashtra Medical Goods Procurement Authority Mumbai · Maharashtra · 21 Jul 2026₹2.4 Cr
- E- 207/MMGPA/ Oral Liquid Syrup (DHSMaharashtra Medical Goods Procurement Authority Mumbai · Maharashtra · 21 Jul 2026₹11.9 Cr
- E-249/MMGPA/Essential Medicines (2025-26)Maharashtra Medical Goods Procurement Authority Mumbai · Maharashtra · 17 Jul 2026₹4.2 Cr
About HINDUSTAN LABORATORIES LIMITED
HINDUSTAN LABORATORIES LIMITED appears as a bidder on 24 government tenders on record, from 11 buyer authorities in 7 states. Of its 22 decided bids, it was awarded 14 — a 63.6% win rate — worth ₹295.8 Cr in total. Its most recent award on record is from 25 Aug 2026.
Its largest buyer by awarded value is Maharashtra Medical Goods Procurement Authority Mumbai, at 66.7% of what it has won, out of 8 authorities that have awarded it work. Most of its awards come from Maharashtra, Himachal Pradesh and Haryana. On priced bids, its median quote is the lowest (L1).
It most often bids against M/S UNICURE INDIA LTD, MAAN PHARMACEUTICALS LTD and Cipla Ltd. M/S UNICURE INDIA LTD bid on 15 of the same tenders and won 10 of them; HINDUSTAN LABORATORIES LIMITED won 7.